According to Samsung Biologics 's latest financial reports the company's current revenue (TTM) is $2.95 B. In 2022 the company made a revenue of $2.29 B an increase over the years 2021 revenue that were of $1.34 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.80 B | 22.03% |
2022 | $2.29 B | 70.56% |
2021 | $1.34 B | 33.88% |
2020 | $1.00 B | 67.07% |
2019 | $0.60 B | 23.77% |
2018 | $0.48 B | 16.23% |
2017 | $0.41 B | 64.54% |
2016 | $0.25 B |